Pure Global AI
Disease / condition

Cardiovascular Disease clinical trials

Free access to 357 studies10+ countriesUpdated daily16 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
357
Total trials
10+
Countries
10+
Sponsors
16
Recruiting
By phase
N/A247
Phase 133
Phase 321
Phase 421
Phase 217
By status
Completed265
Unknown28
Recruiting16
Not yet recruit...13
Terminated13
Top countries
United States of America129
United Kingdom38
Canada25
China13
France11
Top sponsors
Penn State Univers...12
AstraZeneca11
National Heart, Lu...10
GlaxoSmithKline8
VA Office of Resea...7
Recent trials
Latest clinical trials for Cardiovascular Disease
Prevention and Treatment of Cardiovascular Disease
IRCCS Centro Neurolesi Bonino-... · Italy
NCT06413823Recruiting
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
University of North Carolina, ... · United States of America
NCT06263452Not yet recr...
Phase
Phase 4
Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease
Wake Forest University Health ... · United States of America
NCT05972850Not yet recr...
Decoding Your Diet (DYD)
Morehouse School of Medicine · United States of America
NCT05904639Not yet recr...
Phase
Phase 1
Open-label, multicenter, multinational, interventional Clinical Trial to assess Efficacy and Safety of the extemporaneous combination of Nebivolol and Ramipril in hypertensive patients - ARTEMISIA study
Menarini International Operati...
2022-003060-25Ongoing
A randomized, double-blind, placebo-controlled, multicenter trial assessing the reduction of the rate of lipoprotein apheresis after treatment with pelacarsen (TQJ230) compared to placebo in patients with hyperlipoproteinemia(a) and established cardiovascular disease undergoing weekly lipoprotein apheresis in Germany
Novartis Pharma AG
2021-003059-41Ongoing
Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial
Yonsei University · South Korea
NCT05361421Recruiting
Phase
Phase 4
Untitled Trial
Korea University · South Korea
KCT0007029Completed
Phase
Not Applicable
Tailored Interventions to Increase Cardiac Rehabilitation Enrollment
VA Office of Research and Deve... · United States of America
NCT05214989Not yet recr...
Technical Development of Cardiovascular Magnetic Resonance Imaging
National Heart, Lung, and Bloo... · United States of America
NCT04927429Recruiting
Untitled Trial
Amgen K.K. · Australia;Canada;Iceland;United States of America;Denmark;Netherlands
jRCT2031200367Completed
Deep Learning of Retinal Photographs and Atherosclerotic Cardiovascular Disease
Yonsei University · South Korea
NCT04749927Recruiting
Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)
National Human Genome Research... · United States of America
NCT04717336Recruiting
Phase
Early Phase 1
Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects
AstraZeneca · United Kingdom
NCT04686591Completed
Phase
Phase 1
Untitled Trial
Beijing Tsinghua Changgung Hos... · China
ChiCTR2000039640Recruiting
Phase
Early Phase 1
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers
Chong Kun Dang Pharmaceutical · South Korea
NCT04611932Not yet recr...
Phase
Phase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese Subjects
AstraZeneca · United States of America
NCT04588727Recruiting
Phase
Phase 1
A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy Subjects
AstraZeneca · United Kingdom
NCT04492709Completed
Phase
Phase 1
Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers
Chong Kun Dang Pharmaceutical · South Korea
NCT04478097Not yet recr...
Phase
Phase 1
Soluble ST2 and Cardiovascular Outcome
Nanjing Medical University · China
NCT04460131Recruiting
About this profile

Access comprehensive clinical trial information for Cardiovascular Disease through Pure Global AI's free database. This collection includes 357 clinical trials across multiple phases including N/A, Phase 1, Phase 3. Currently, 16 trials are actively recruiting participants.

Research for Cardiovascular Disease is being conducted in United States of America, United Kingdom, Canada and 7+ other countries. Leading sponsors include Penn State University and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 357 clinical trials studying Cardiovascular Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Penn State University, AstraZeneca, National Heart, Lung, and Blood Institute (NHLBI), among others.